Rosetta Genomics Ltd. — Form D

Rosetta Genomics Ltd. of REHOVOT, L3, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-01. The offering totals $1.9M, of which $1.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Isaac Shoshani BentwichDirectorRehovot, L3
Gerald Shoshani DogonDirectorRehovot, L3
Brian A MarkisonDirectorRehovot, L3
Joshua Shoshani RosensweigDirectorRehovot, L3
David Shoshani SidranskyDirectorRehovot, L3
Tali Shoshani Yaron-EldarDirectorRehovot, L3
Ayelet ChajutExecutive OfficerRehovot, L3
Keren GivliExecutive OfficerRehovot, L3
Tami Fishman JutkowitzExecutive OfficerRehovot, L3
Tzipora Shoshani KupitzExecutive OfficerRehovot, L3
David SidranskyDirectorGermantown, MD
BRIAN MARKISONDirectorROCKVILLE, MD
Oded BiranExecutive OfficerSouthborough, MA
Kenneth BerlinDirectorMonmouth Junction, NJ
Kenneth BerlinExecutive OfficerMonmouth Junction, NJ
Tali Yaron-EldarDirectorTel Aviv, L3
Ranit AharonovExecutive OfficerRehovot, L3
Joshua RosensweigDirectorRehovot, L3
Tomer AssisExecutive OfficerRehovot, L3
Gerald DogonDirectorRehovot, L3
Racheli Shoshani VizmanExecutive OfficerRehovot, L3
Yoav Shoshani CheloucheDirectorRehovot, L3
Moshe Shoshani ManyDirectorRehovot, L3
Tina Fishman EdmonstonExecutive OfficerRehovot, L3

Other filings by this issuer (5)

FiledFormOfferingSold
2012-02-09D$1.8M$1.8M
2011-03-07D/A$2.7M$2.7M
2011-03-07D/A$2.5M$2.5M
2011-03-03D$2.7M$2.7M
2011-03-03D$2.5M$2.5M

More